In a new article in the journal Australian Prescriber, there is a warning that combination painkillers cause more side effects and may not provide the relief promised. This comes from the National Prescribing Service (NPS), Australia’s medicine review body. Continue Reading

Perrigo Company announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for butoconazole nitrate vaginal cream, 2% and that is has notified KV Pharmaceutical Company, the owner of the New Drug Application as well as FemmePharma, the listed owner of the patent, of its ANDA filing. KV is a licensee under the patent. Perrigo believes it is first-to-file on this product. Continue Reading

B. Braun Medical Inc. announced today the availability of large volume heparin infusion solutions. Continue Reading

Parkinson’s disease affects nearly 80,000 Australians and is a severely debilitating nerve disorder that leads to tremors, muscle stiffness, uncharacteristic movements, loss of balance and slowing of movements. Continue Reading

Reportlinker.com announces that a new market research report is available in its catalogue: Global Pancreatic Cancer Drugs industry. Continue Reading

Through a grant awarded by the U.S. Environmental Protection Agency (EPA), the University of Maine’s Center on Aging has completed the first statewide mail-back pilot program for managing pharmaceutical waste from consumers. Continue Reading

Research and Markets has announced the addition of the “Global Pharmaceuticals” report to their offering. Continue Reading

Hosted by Global Leaders Institute, “VacChina 2010″, a Vaccine Development Summit to be held from September 15-16, 2010, will bring together the world’s major vaccine players and their respective senior level representatives to Shanghai, the heart of China’s biopharmaceutical innovation. Continue Reading

NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced that its Suzhou Erye Pharmaceutical subsidiary (“Erye”) recently received approval from the State Food and Drug Administration (SFDA) in China to manufacture the sterile active pharmaceutical ingredient (API) of the anti-infective cloxacillin sodium. Continue Reading

The U.S. Food and Drug Administration today warned health care providers and consumers about counterfeit surgical mesh being distributed in the United States under the C. R. Bard/Davol brand name. Surgical mesh products are used to reinforce soft tissue where weakness exists. Continue Reading